Watch Ticker

Fate Therapeutics, Inc.

Go to Fate Therapeutics, Inc. Website

$1.04

-0.04 (-3.70%)

Live

Previous Close

$1.08

Day Range

$0 - $0

Previous Day Range

$1.05 - $1.13

Market Cap

$121.5 million USD

Day Vol.

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is compri...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress

Fate Therapeutics announced that clinical data from its ongoing Phase 1 trial of FT819, an off-the-shelf CAR T-cell product candidate, in patients with moderate-to-severe systemic lupus erythematosus (SLE) will be presented at the EULAR 2025 Congress.

Related tickers: FATE.

Read Full Article

N/A - Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted restricted stock units representing 32,200 shares of its common stock to two newly-hired non-executive employees. The grants were approved by the Compensation Committee and granted under the Company's Amended and Restated Inducement Equity Plan.

Related tickers: FATE.

Read Full Article

Trending Tickers

Please sign in to view